Market Cap (In USD)
4.7 Million
Revenue (In USD)
-
Net Income (In USD)
-2.38 Million
Avg. Volume
428.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.102-1.13
- PE
- -4.33
- EPS
- -0.15
- Beta Value
- -1.688
- ISIN
- US61945M1018
- CUSIP
- 61945M101
- CIK
- 836564
- Shares
- 7242140.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Steven W. King
- Employee Count
- -
- Website
- https://www.mosaicie.com
- Ipo Date
- 2013-01-02
- Details
- Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
More Stocks
-
MOLDTECHMold-Tek Technologies Limited
MOLDTECH
-
003960Sajodaerim Corporation
003960
-
IAR-B
-
CHWRF
-
SKA-BSkanska AB (publ)
SKA-B
-
EYE
-
ARIESAries Agro Limited
ARIES
-
SUNS